Francesca Sperti scite author profile

A Phase IV, prospective, observational cohort study examining patients changed from Atripla to Stribild for continued suppression of viral load, effect on CD-4 cells, quality of life and sleep using blood tests and standardized questionnaires. While continuing to control the virus to acceptable levels, CD 4 counts were noted to rise and patients experienced fewer CNS side effects. Sleep quality was also improved.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Francesca Sperti

Preoperative and Postoperative Evaluation of New Double Mesh Carotid Stents with Contrast-Enhanced Ultrasound and Diffusion-Weighted Imaging

Retrograde Use of Gore Hybrid Vascular Graft for a Complex Carotid Tandem Lesion

Early Carotid Endarterectomy Provides a Better Neurological Outcome in Symptomatic Patients: A Single-Center Experience

Drug eluting stents in a real world setting: long femoropopliteal lesions and complex patients. A single center experience

Contact Info

Product

Resources

About